Tung Tak Sim Biotechnology CompanyLtd

Phone
00852 28324822

Email
[email protected]

Address
Guangdong Province, Shenzhen City, Guangming District, Guangming Street, Bi Yan Community, Huaqiang Creative Industry Park, Building 4, Block B, Room 404

Superbug Paper and Preprint

View: 24 Update: 2026-07-29 Category: Superbug Research

Multidimensional Evidence of Mulberry Dandelion Beverage Inhibiting Multidrug-Resistant Bacteria

In vitro antibacterial, real sputum samples, and clinical cases jointly constitute multidimensional evidence

Introduction

The study evaluates the antibacterial activity of mulberry dandelion beverage against multidrug-resistant bacteria through in vitro antibacterial experiments, real sputum sample testing, and clinical case observations. The research shows that it exhibits inhibitory effects on Pseudomonas aeruginosa, carbapenem-resistant Acinetobacter baumannii, penicillin-resistant Streptococcus pneumoniae, etc., and possesses antibacterial characteristics distinct from traditional antibiotics.

The related paper has been published on the preprint platform: "Research Square" link: https://www.researchsquare.com/article/rs-4956501/v1

In vitro test paper, mulberry dandelion soup effectively inhibits multiple superbugs.

View paper PDF

 桑葚蒲公英可显著抑制多重耐药菌-多维证据.pdf 

Multidrug-Resistant Bacterial Infection Critical Case Study

Real-world observation from severe infection, inflammatory indicators, nutritional status to anti-infection outcome

Introduction

The study focuses on a critically infected patient infected with multidrug-resistant Klebsiella pneumoniae. The patient had undergone multiple ICU treatments and various antibiotic therapies, yet infection control remained challenging. Continuous culture and follow-up showed that during the 12th to 18th week of hospitalization and the 6-week follow-up after discharge, multidrug-resistant Klebsiella pneumoniae was no longer detected, and lung inflammation and pleural effusion gradually transitioned from extensive lesions to basic absorption. This study provides real-world evidence for the long-term control of multidrug-resistant bacteria in complex critical infection scenarios.

The related paper has been published on the preprint platform: "SSRN" link: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4967550

View paper PDF

 多重耐药菌感染危重合并ALS个案论文.pdf 

Clinical Case Report of Long-term Infection with Multidrug-Resistant Acinetobacter baumannii Complicated with ALS

Observation of pathogen exit from long-term multidrug-resistant Acinetobacter baumannii infection

Introduction:

The study focuses on a highly concerning nosocomial infection pathogen—multidrug-resistant Acinetobacter baumannii. The patient's infection persisted for over a year, with limited effects from conventional anti-infective treatments. The paper records that after receiving herbal nutrition intervention, cultures on May 17 and June 8 no longer detected Acinetobacter baumannii; infection reappeared during a brief discontinuation, and after resuming intervention, the culture on June 19 showed no bacterial growth, with four subsequent cultures continuing to support the absence of pathogen detection. This study presents the continuous changes in the process of long-term dominant drug-resistant pathogens transitioning from persistent presence to infection exit.

The related paper has been published on the preprint platform: "ChinaXiv" link: https://chinaxiv.org/abs/202501.00193

View paper PDF

 针对长期感染耐多药鲍曼不动杆菌合并急性肺部感染的本草营养干预临床病例报告.pdf 

Analysis of Drug-Resistant Burden Evolution and Outcome in Two Cases of Late-Stage ALS with Severe Infection

From dominant pathogens, drug sensitivity changes to improved infection ecology in later tracking

Introduction

The study records the long-term pathogen evolution of two late-stage ALS patients under severe infection. Case A initially had long-term detection of multidrug-resistant Acinetobacter baumannii, accompanied by recurrent Pseudomonas aeruginosa infections; subsequently, the original dominant drug-resistant pathogens gradually exited the continuous dominant state, and the newly emerged Klebsiella pneumoniae and Escherichia coli did not exhibit multidrug-resistant phenotypes overall. Case B's highly drug-resistant Klebsiella pneumoniae did not recur, and the subsequently detected Pseudomonas aeruginosa remained sensitive to multiple common drugs such as amikacin, cefepime, imipenem, and meropenem. The study presents real-world clues of superbug infections transitioning from "long-term high drug resistance dominance" to "later reduced drug resistance burden, easier infection control".

The related paper has been published on the preprint platform: "ChinaXiv" link: https://chinaxiv.org/abs/202605.00009

 针对两例晚期肌萎缩侧索硬化症患者严重感染的本草营养干预:耐药负荷演变与治疗结局.pdf 


Email